Covid-2019 - 2022-08-31

In "Recommended Reading," a fawning feature in the New York Times about the FDA approving the new Omicron-specific booster vaccines -- developed "with extraordinary speed, a testament to the mRNA technology that Pfizer and Moderna have harnessed since the early months of the coronavirus outbreak." It's way down in the article -- even deeper than the ninth paragraph of our trusty ninth paragraph rule -- that "Regulators authorized the vaccine without results from human trials, which have just started." Astonishing.